Bio-Rad Laboratories (NYSE:BIO – Get Free Report) and TREES (OTCMKTS:CANN – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.
Earnings and Valuation
This table compares Bio-Rad Laboratories and TREES”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Bio-Rad Laboratories | $2.58 billion | 2.98 | $759.90 million | $27.91 | 10.21 |
| TREES | $13.66 million | 0.29 | -$3.48 million | ($0.02) | -1.73 |
Analyst Ratings
This is a breakdown of recent ratings and price targets for Bio-Rad Laboratories and TREES, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bio-Rad Laboratories | 1 | 2 | 3 | 0 | 2.33 |
| TREES | 0 | 0 | 0 | 0 | 0.00 |
Bio-Rad Laboratories presently has a consensus price target of $358.50, suggesting a potential upside of 25.86%. Given Bio-Rad Laboratories’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Bio-Rad Laboratories is more favorable than TREES.
Risk and Volatility
Bio-Rad Laboratories has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500. Comparatively, TREES has a beta of -0.65, suggesting that its share price is 165% less volatile than the S&P 500.
Profitability
This table compares Bio-Rad Laboratories and TREES’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Bio-Rad Laboratories | 29.42% | 3.86% | 2.70% |
| TREES | N/A | N/A | N/A |
Institutional and Insider Ownership
65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 11.3% of TREES shares are owned by institutional investors. 17.1% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 45.0% of TREES shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Summary
Bio-Rad Laboratories beats TREES on 13 of the 14 factors compared between the two stocks.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
About TREES
Trees Corporation provides products and services to the regulated cannabis industry in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and retail dispensary store in Englewood, Colorado, as well as retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Lakewood, Colorado.
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
